![Pain, fatigue may persist in PsA despite biologic therapy | Latest news for Doctors, Nurses and Pharmacists | Rheumatology Pain, fatigue may persist in PsA despite biologic therapy | Latest news for Doctors, Nurses and Pharmacists | Rheumatology](https://pubmiddleware.mims.com/resource/image/5270D1AA-F294-4322-A7A1-AA7900EA06D0/OriginalThumbnail/THUMBNAIL_shutterstock_1148963603.jpg)
Pain, fatigue may persist in PsA despite biologic therapy | Latest news for Doctors, Nurses and Pharmacists | Rheumatology
![Enzalutamid verbessert Prognose unabhängig von PSA-Wert bei Therapiebe - Onkologie - Universimed - Medizin im Fokus Enzalutamid verbessert Prognose unabhängig von PSA-Wert bei Therapiebe - Onkologie - Universimed - Medizin im Fokus](https://www.universimed.com/__image/a/2247933/alias/xxxl/v/1/c/9/ar/1-1/fn/8_635P_Prostata.jpg)
Enzalutamid verbessert Prognose unabhängig von PSA-Wert bei Therapiebe - Onkologie - Universimed - Medizin im Fokus
![Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery | Imaging Technology News Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery | Imaging Technology News](http://www.itnonline.com/sites/default/files/ProstateCancerNuclearCTFusionInfinittXelisFusion.jpg)
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery | Imaging Technology News
![Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival Cancers | Free Full-Text | Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival](https://pub.mdpi-res.com/cancers/cancers-14-00149/article_deploy/html/images/cancers-14-00149-ag-550.jpg?1640771400)